share_log

Allegro MicroSystems Announces Pricing of Primary Offering

Allegro MicroSystems Announces Pricing of Primary Offering

allegro microsystems 宣布首次发行定价
Allegro MicroSystems ·  07/24 00:00

MANCHESTER, N.H., July 24, 2024 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. ("Allegro") (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the pricing of a primary offering of 25,000,000 shares of common stock at a public offering price of $24.00 per share, resulting in gross proceeds of $600,000,000 to Allegro (or $579,000,000 to Allegro after giving effect to the underwriters' discount of $0.84 per share). In addition, Allegro has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. Proceeds from the offering, together with cash on hand or additional borrowings under Allegro's term loan facility or revolving credit facility, will be used to repurchase shares from Allegro's majority shareholder, Sanken Electric Co., Ltd. ("Sanken") at a price per share equal to the price per share at which the underwriters will purchase shares of our common stock in the equity offering from Allegro. On an as adjusted basis after giving effect to the offering and the share repurchase, Sanken will hold approximately 33.2% (or 32.5% if the underwriters' option to purchase additional shares of Allegro's common stock is exercised in full) of Allegro's outstanding common stock. The offering is expected to close on or about July 26, 2024, subject to the satisfaction of customary closing conditions.

2024年7月24日,新罕布什尔州曼彻斯特(GLOBE NEWSWIRE) - Allegro Microsystems公司(以下简称“Allegro”)(纳斯达克:ALGM)是动力和传感解决方案的全球领导者运动控制和高效系统,今天宣布股票的发行价格为24.00美元,公开发行价,每股共25,000,000股,总收益为6亿美元。 Allegro的净收益为5.79亿美元(考虑到承销商折扣每股0.84美元)。此外,Allegro已经授予承销商30天的选择权,以购买额外的3,750,000股普通股,公开发行价,扣除承销折扣和佣金。该发行所得收入,加上Allegro手头的现金或Allegro的期限贷款或循环信用设施的额外借款,将用于以每股等于承销商从Allegro购买普通股的价格回购来自Allegro的大部分股东Sanken Electric Co.,Ltd.(以下简称“Sanken”)。考虑到发行和股票回购后,Sanken将持有Allegro已发行普通股的约33.2%(若承销商行使购买Allegro普通股的额外行权,Sanken持有的股份将为32.5%)。该发行预计将于2024年7月26日前后结束,视情况而定。

Barclays, Morgan Stanley and UBS Investment Bank are acting as joint lead book-running managers for the offering. BofA Securities, Mizuho and Jefferies are acting as book-running managers for the offering. PJT Partners and Needham & Company are acting as co-managers for the offering. PJT Partners is also acting as financial advisor to Allegro.

巴克莱(Barclays)、摩根士丹利(Morgan Stanley)和瑞银投资银行(UBS Investment Bank)担任本次发行的联合主承销商。美枝证券(BofA Securities)、瑞穗证券和杰富瑞证券(Jefferies)担任本次发行的主承销商。PJt Partners和Needham & Company担任本次发行的联席承销商。PJt Partners还担任Allegro的财务顾问。

This offering is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the "SEC") on July 23, 2024. The shares of common stock will be offered only by means of a prospectus supplement and the accompanying prospectus forming a part of the effective shelf registration statement. Before you invest, you should read the prospectus in that registration statement and the documents incorporated by reference in that registration statement, as well as the prospectus supplement related to this offering.

本次发行是根据2024年7月23日向美国证券交易委员会("SEC")提交的有效货架注册声明进行的。普通股将仅通过发行的配售说明书和构成有效货架注册声明的附带的招股说明书提供出售。在您投资之前,应阅读招股说明书及其所引用的在该注册声明中被纳入的文件,以及与本次发行相关的配售说明书。

Copies of the final prospectus supplement related to this offering and the accompanying prospectus may be obtained, when available, from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone (toll-free): (888) 603-5847 or by emailing: barclaysprospectus@broadridge.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, New York, New York 10014, or by emailing: prospectus@morganstanley.com; or UBS Securities LLC, Attention: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, by telephone: (888) 827-7275 or by emailing: ol-prospectusrequest@ubs.com. You may also obtain these and the other documents referred to above for free by visiting the SEC's website at www.sec.gov.

本发行有关最终招股说明书及其附属招股说明书的副本,如有需要,可从以下地点获得:Barclays Capital Inc.,c/o Broadridge Financial Solutions,1155 Long Island Avenue,Edgewood,NY 11717,电话(免费电话):(888) 603-5847或通过电子邮件:barclaysprospectus@broadridge.com;摩根士丹利证券有限公司,Attention:Prospectus Department,180 Varick Street,New York,New York 10014,或通过电子邮件:prospectus@morganstanley.com;或UBS Securities LLC,Attention:Prospectus Department,1285 Avenue of the Americas,New York,NY 10019,电话:(888) 827-7275或通过电子邮件发送:ol-prospectusrequest@ubs.com。您也可以免费访问美国证券交易委员会网站www.sec.gov了解上述文件。

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Tonix Pharmaceuticals Holding Corp.*,是一家完全整合的生物制药公司,致力于发展富有创新性的治疗和预防潜在疾病的制剂。公司正在研发针对纤维肌痛患者的产品TNX-102 SL,已经完成了两项具有统计学意义的3期研究。TNX-102 SL也正在被开发用于治疗急性压力反应以及类纤维肌痛的长期COVID。Tonix的神经系统药物组合包括TNX-1300(可卡因酯酶),这是一种用于治疗可卡因中毒、被授予“突破性疗法”称号的生物制品。Tonix的免疫学研发组合包括生物制品,用于治疗器官移植排斥、自身免疫和癌症,包括TNX-1500,这是一种人源单克隆抗体,靶向CD40L(CD40L或CD154)用于预防异体移植器官排斥并用于治疗自身免疫性疾病。Tonix在罕见疾病和传染病领域的正在研发中的产品。商业子公司Tonix Medicines市场上销售Zembrace SymTouch(舒马曲坦注射液)3毫克和Tosymra(舒马曲坦鼻喷剂)10毫克,用于成年急性偏头疼的治疗。

About Allegro MicroSystems

关于阿莱格罗微系统

Allegro MicroSystems, Inc. is a leading global designer, developer, fabless manufacturer and marketer of sensor integrated circuits ("ICs") and application-specific analog power ICs enabling emerging technologies in the automotive and industrial markets. Allegro's diverse product portfolio provides efficient and reliable solutions for the electrification of vehicles, automotive ADAS safety features, automation for Industry 4.0 and power-saving technologies for data centers and clean energy applications.

Allegro MicroSystems,Inc.是一家领先的传感器集成电路("ICs")和应用特定模拟功率ICs的全球设计师、开发商、无晶圆制造商和市场营销商,可实现汽车和工业市场的新兴技术。 Allegro的多样化产品组合为车辆电气化,汽车ADAS安全功能,工业4.0自动化和节能技术以及数据中心和清洁能源应用提供高效可靠的解决方案。

About Sanken

关于匠电

Sanken's mission as a company is to provide optimal solutions in the broad and expansive field of electricity and electronics with semiconductors, its core business, power electronics and peripheral fields. Sanken provides products globally for the increasingly electrified automotive industry, as well as for white goods and industrial equipment, which are becoming more energy efficient as demand for electricity increases. Sanken Electric works to constantly innovate its technological capabilities and provides products of assured quality to help solve global environmental and social issues and further develop industry, the economy and culture.

Sanken作为一家公司,其使命是为半导体、电源电子和周边领域在电力电子和小家电、工业设备及其他能源设备磁电化方面提供最佳方案。Sanken为全球日益电气化的汽车行业,以及因需求增加对电力需求更高效的白色家电和工业设备提供产品。Sanken Electric致力于不断创新技术能力,并提供品质保证的产品,以帮助解决全球环境和社会问题,并进一步发展工业、经济和文化。

Forward-Looking Statements

前瞻性声明

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the sale of common stock in the offering, the closing of the offering and the repurchase of shares from Sanken, each as described above. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the factors discussed under the caption "Risk Factors" in the prospectus supplement related to this offering, our Annual Report on Form 10-K for the fiscal year ended March 29, 2024, filed with the SEC on May 23, 2024, and our other filings with the SEC, any of which could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change, except as required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

本新闻稿包含《1995年证券诉讼法》中规定的前瞻性声明。本新闻稿中包含的所有与历史事实无关的声明均应视为前瞻性声明,包括有关本次发行普通股、发行结束、按上述说明从Sanken回购股份的声明。这些前瞻性声明基于管理层的当前预期。这些声明既不构成承诺也不构成保证,但涉及已知和未知的风险、不确定性和其他重要因素,这些因素可能导致我们的实际结果、绩效或成就与前瞻性声明中表明的任何未来结果、绩效或成就实质上有所不同。这些因素包括但不限于在与本次发行有关的招股说明书的“风险因素”标题下讨论的事项,以及我们于2024年5月23日向美国证券交易委员会提交的2016年10K表格上的其他提交,及我们向美国证券交易委员会的其他提交,任何这些都可能导致实际结果与本新闻稿中所作的前瞻性声明所示结果有实质性不同。这些前瞻性声明代表管理层在发布日的估计。虽然我们可能在将来某个时间选择更新这些前瞻性声明,但即使随后发生的事件导致我们的观点发生变化,我们也拒绝任何义务这样做,除法律规定之外。这些前瞻性声明不应作为我们在本新闻稿发布日以后的任何日期上的看法。

Contact:
Jalene Hoover
VP of Investor Relations & Corporate Communications
+1 (512) 751-6526
jhoover@allegromicro.com

联系方式:
Jalene Hoover
投资者关系和企业通讯副总裁
+1 (512) 751-6526
jhoover@allegromicro.com


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发